
AAM All Access Podcast - AAM CEO Dan Leonard convenes industry and policy experts to explore why the Inflation Reduction Act (f/k/a Build Back Better) reduces generic and biosimilar competition.
AAM’s “Voices of Access” report features patients across the country speaking about the importance of generic and biosimilar medicines in their lives. This annual publication tells the impact that accessible medicines have on everyday Americans – on their health journeys, their economic well-being and their daily lives.
Click here for mobile-friendly version.
Read their story on the AAM blog: